loadpatents
name:-0.0070030689239502
name:-0.009972095489502
name:-0.0015938282012939
Maurer-Fogy; Ingrid Patent Filings

Maurer-Fogy; Ingrid

Patent Applications and Registrations

Patent applications and USPTO patent grants for Maurer-Fogy; Ingrid.The latest application filed is for "tnf receptors, tnf binding proteins and dnas coding for them".

Company Profile
0.10.3
  • Maurer-Fogy; Ingrid - Vienna AT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method of ameliorating the harmful effects of TNF using a polypeptide having the ability to bind to TNF
Grant 7,282,483 - Hauptmann , et al. October 16, 2
2007-10-16
TNF receptors, TNF binding proteins and DNAs coding for them
Grant 7,264,944 - Hauptmann , et al. September 4, 2
2007-09-04
TNF binding proteins
Grant 7,238,776 - Hauptmann , et al. July 3, 2
2007-07-03
TNF receptors, TNF binding proteins and DNAs coding for them
App 20020183485 - Hauptmann, Rudolf ;   et al.
2002-12-05
TNF receptors, TNF binding proteins and DNAs coding for them
App 20020155112 - Hauptmann, Rudolf ;   et al.
2002-10-24
TNF receptors, TNF binding proteins and DNAS coding for them
Grant 6,440,693 - Hauptmann , et al. August 27, 2
2002-08-27
TNF receptors, TNF binding proteins and DNAs coding for them
App 20020090676 - Hauptmann, Rudolf ;   et al.
2002-07-11
TNF Receptors, TNF binding proteins and DNAs coding for them
Grant 6,271,346 - Hauptmann , et al. August 7, 2
2001-08-07
TNF receptors, TNF binding proteins and DNAs coding for them
Grant 6,221,675 - Hauptmann , et al. April 24, 2
2001-04-24
Process and vector for expressing alpha-interferon in E. coli
Grant 5,710,027 - Hauptmann , et al. January 20, 1
1998-01-20
Human manganese superoxide dismutase (hMn-SOD)
Grant 5,436,162 - Heckl , et al. * July 25, 1
1995-07-25
Process for preparing and purifying alpha-interferon
Grant 5,196,323 - Bodo , et al. March 23, 1
1993-03-23
Hybrid interferons, their use as pharmaceutical compositions and as intermediate products for the preparation of antibodies and the use thereof and processes for preparing them
Grant 4,917,887 - Hauptmann , et al. April 17, 1
1990-04-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed